RxAlly hires Kerr Drug executive

Rebecca Chater appointed VP health outcomes for 22,000-pharmacy network

LEESBURG, Va. — A network of pharmacies formed with the goal of helping patients achieve better health outcomes while reducing costs has appointed a new executive to its leadership team.

RxAlly announced the appointment of Rebecca Chater as VP health outcomes. Chater, a pharmacist who has worked in clinical services for 20 years, will be responsible for providing leadership and clinical management of RxAlly solutions and integrating business development with clinical staff and operations.

"Rebecca's impressive credentials and extensive track record of success speaks to both her tremendous expertise and her genuine passion for enhancing the value of community-based, patient-focused quality pharmacy care," RxAlly CEO Bruce Roberts said. "We are very fortunate to have her on board. Her role will be critical in helping RxAlly develop and implement on a national scale industry-leading clinical service programs that support RxAlly's member pharmacies in providing the highest quality pharmacy care available."

Most recently, Chater was an EVP at Kerr Drug subsidiary Kerr Health.

Interested in this topic? Sign up for our weekly DSN Collaborative Care e-newsletter. 

Login or Register to post a comment.